PROLATTINA E MASTOPATIE = PROLACTINE ET MASTOPATHIEDOGLIOTTI L; MUSSA A.1980; MINERVA ENDOCRINOL.; ITA; DA. 1980; VOL. 5; NO 2; PP. 147-152; BIBL. 46 REF.Article

PRIMI RISULTATI NEL TRATTAMENTO DEI CARCINOMI METASTATICI DELLA MAMMELLA ORMONODIPENDENTI CON L'ASSOCIAZIONE DI BROMO CRIPTINA E MEDROSSIPROGESTERONE ACETATO. = PREMIERS RESULTATS DU TRAITEMENT DE TUMEURS METASTATIQUES DE LA GLANDE MAMMAIRE HORMONODEPENDANTE, AVEC L'ASSOCIATION BROMOCRYPTINE+MEDROXYPROGESTERONE ACETATEMUSSA A; DOGLIOTTI L; DI CARLO F et al.1977; MINERVA MED.; ITAL.; DA. 1977; VOL. 68; NO 32; PP. 2233-2244; ABS. ANGL.; BIBL. 3 P. 1/2Article

VALUTAZIONE GLOBALE DEI RISULTATI OTTENUTI NEL TRATTAMENTO DEI CARCINOMI METASTATICI DELLA MAMMELLA CON TERAPIA COMBINATA MAP-ALTE DOSI E BROMOCRIPTINA = EVALUATION GLOBALE DES RESULTATS OBTENUS DANS LE TRAITEMENT DES CANCERS METASTATIQUES DU SEIN PAR L'ASSOCIATION DE MAP A HAUTES DOSES ET DE BROMOCRIPTINEMUSSA A; DOGLIOTTI L; DI CARLO F et al.1980; MINERVA MED.; ITA; DA. 1980; VOL. 71; NO 6; PP. 391-400; ABS. ENG; BIBL. 46 REF.Article

European multicentre trial of bromocriptine in cyclical mastalgiaMANSEL, R. E; DOGLIOTTI, L.Lancet (British edition). 1990, Vol 335, Num 8683, pp 190-193, issn 0140-6736, 4 p.Article

LE TRAITEMENT DU CANCER DU SEIN AVANCE AVEC MPA A DOSES ELEVEES ET BROMOCRYPTINE: RESULTATS APRES 5 ANNEES DE THERAPIEMUSSA A; DOGLIOTTI L; DI CARLO F et al.1982; LYON CHIR.; ISSN 0024-7782; FRA; DA. 1982; VOL. 78; NO 4; PP. 256-259; ABS. ENG; BIBL. 15 REF.Article

IL CARCINOMA MAMMARIO MASCHILE. REVISIONE DELLA LETTERATURA E CONTRIBUTO CASISTICO = LE CANCER DU SEIN DANS LE SEXE MASCULIN. REVUE DE LA LITTERATURE ET PRESENTATION DE CASMUSSA A; DOGLIOTTI L; ALABISO O et al.1982; MINERVA CHIR.; ISSN 0026-4733; ITA; DA. 1982; VOL. 37; NO 10; PP. 875-881; ABS. ENG; BIBL. 46 REF.Article

The endocrine basis of benign breast disordersDOGLIOTTI, L; ORLANDI, F; ANGELI, A et al.World journal of surgery. 1989, Vol 13, Num 6, pp 674-679, issn 0364-2313Article

The clinical management of neuroendocrine tumors with long-acting repeatable (LAR) octreotide: Comparison with standard subcutaneous octreotide therapyDOGLIOTTI, L; TAMPELLINI, M; STIVANELLO, M et al.Annals of oncology. 2001, Vol 12, pp 105-109, issn 0923-7534, SUP2Conference Paper

Modulation of cytotoxic drug activity by mitotane and lonidamine in human adrenocortical carcinoma cellsVILLA, R; ORLANDI, L; BERRUTI, A et al.International journal of oncology. 1999, Vol 14, Num 1, pp 133-138, issn 1019-6439Article

Weekly gemcitabine and cisplatin combination therapy in patients with transitional cell carcinoma of the urothelium : A phase II clinical trialVON DER MAASE, H; ANDERSEN, L; CRINO, L et al.Annals of oncology. 1999, Vol 10, Num 12, pp 1461-1465, issn 0923-7534Article

Neuroendocrine oncology - biological and clinical aspects, 22-24 March 2000, Turin, ItalyDOGLIOTTI, L; ANGELI, A; ABRAHAMSSON, P.-A et al.Annals of oncology. 2001, Vol 12, issn 0923-7534, 165 p., SUP2Conference Proceedings

Combination chemotherapy with carboplatin and methotrexate in the treatment of advanced urothelial carcinoma : a phase II studyDOGLIOTTI, L; BERTETTO, O; BERRUTI, A et al.American journal of clinical oncology. 1995, Vol 18, Num 1, pp 78-82, issn 0277-3732Article

Chemotherapy with dacarbazine and 5-fluorouracil in advanced medullary thyroid cancerORLANDI, F; CARACI, P; BERRUTI, A et al.Annals of oncology. 1994, Vol 5, Num 8, pp 763-765, issn 0923-7534Article

Biochemistry of breast cyst fluid : an approach to understanding intercellular communication in the terminal duct lobular unitsDOGLIOTTI, L; ORLANDI, F; CARACI, P et al.Annals of the New York Academy of Sciences. 1990, Vol 586, pp 17-28, issn 0077-8923, 12 p.Conference Paper

Prolactin and thyrotropin response to thyrotropin-releasing hormone in premenopausal women with fibrocystic disease of the breastDOGLIOTTI, L; FAGGIUOLO, R; FERUSSO, A et al.Hormone research. 1985, Vol 21, Num 3, pp 137-144, issn 0301-0163Article

Transient increase in total serum alkaline phosphatase predicts radiological response to systemic therapy in breast cancer patients with osteolytic and mixed bone metastasesBERRUTI, A; OSELLA, G; RAUCCI, C. A et al.Oncology. 1993, Vol 50, Num 4, pp 218-221, issn 0030-2414Article

Neuroendocrine tumors in the brainCAVALLA, P; SCHIFFER, D.Annals of oncology. 2001, Vol 12, pp 131-134, issn 0923-7534, SUP2Conference Paper

Neuroendocrine pathogenesis in adenocarcinoma of the prostateHANSSON, J; ABRAHAMSSON, P.-A.Annals of oncology. 2001, Vol 12, pp 145-152, issn 0923-7534, SUP2Conference Paper

Cations and dehydroepiandrosterone-sulfate in cyst fluid of pre- and menopausal patients with gross cystic disease of the breast. Evidence for the existence of subpopulations of cystsDOGLIOTTI, L; ORLANDI, F; TORTA, M et al.European journal of cancer & clinical oncology. 1986, Vol 22, Num 11, pp 1301-1307, issn 0277-5379Article

A new magnesium-containing PEG-electrolyte solution for the oral lavage of the colonCITTADINI, G; DE CICCO, E; CITTADINI, G. JR et al.Clinical radiology. 1999, Vol 54, Num 3, pp 160-163, issn 0009-9260Article

Expression of neuropeptide Y receptors in human prostate cancer cellsMAGNI, P; MOTTA, M.Annals of oncology. 2001, Vol 12, pp 27-29, issn 0923-7534, SUP2Conference Paper

Neuroendocrine differentiation in human prostate cancer. Morphogenesis, proliferation and androgen receptor statusBONKHOFF, H.Annals of oncology. 2001, Vol 12, pp 141-144, issn 0923-7534, SUP2Conference Paper

The gut as the largest endocrine organ in the bodyAHLMAN, H; NILSSON, O.Annals of oncology. 2001, Vol 12, pp 63-68, issn 0923-7534, SUP2Conference Paper

Levels of eighteen non-conjugated and conjugated steroids in human breast cyst fluid : relationships with cyst typeBELANGER, A; CARON, S; LABRIE, F et al.European journal of cancer & clinical oncology. 1990, Vol 26, Num 3, pp 277-281, issn 0277-5379Article

Shifted distribution of cation-related cyst types in post-menopausal patients with gross cystic disease of the breastORLANDI, F; DOGLIOTTI, L; TORTA, M et al.Maturitas (Amsterdam). 1987, Vol 9, Num 1, pp 17-23, issn 0378-5122Article